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The presence of the genes engBF (endo--N-acetylgalactosaminidase) and afcA (1,2--L-fucosidase) was
detected in several intestinal Bifidobacterium isolates. Two strains of Bifidobacterium bifidum contained both
genes, and they were able to degrade high-molecular weight porcine mucin in vitro. The expression of both
genes was highly induced in the presence of mucin.
The human intestine is covered with a protective mucus
layer, which plays an important role in the mucosal barrier
system and is crucial for preventing adhesion and binding by
many pathogens, toxins, and other damaging agents present in
the intestinal lumen (5, 13). The mucus mainly consists of
water (ca. 95%) and glycoproteins (1 to 10%), as well as elec-
trolytes, antibodies, and nucleic acids (13). Furthermore, this
mucus has been reported to serve as a source of nutrients for
bacterial growth (4). Thus, bacteria that are able to survive,
multiply, and colonize within the mucus layer display an adap-
tative advantage to persist in the gastrointestinal tract. Never-
theless, the interactions of the gut microbiota, especially pro-
biotic bacteria, with intestinal mucus are poorly understood.
Bifidobacterium species are common inhabitants of the
gastrointestinal tract, and they have received special attention
because of their health-promoting effects in humans. The long
history of safe use of these bacteria in the functional food
industry remains the best proof of their safety, as the risk of
infection is assumed to be very low (18). Adherence to mucus
is one of the main in vitro tests for the study of probiotic strains
(2), and some bifidobacteria have been found to be highly
adhesive (8); however, mucin degradation has been considered
an undesirable characteristic of probiotics (21), since it is be-
lieved that it could favor alteration of the intestinal mucosal
barrier. In this context, the aim of this work was to evaluate the
presence of genes potentially involved in mucus degradation
and the ability of several Bifidobacterium strains to grow in the
presence of mucus as the only carbon source and to degrade it.
Two bifidobacterial exocellular glycosidases potentially act-
ing on sugar chains of mucin glycoproteins have been de-
scribed (9). They have been functionally characterized by using
synthetic substrates, but their involvement in intestinal mucin
degradation has never been studied before. The product of the
engBF gene of Bifidobacterium longum JCM1217 is an endo--
N-acetylgalactosaminidase (E.C. 3.2.1.97). This enzyme cata-
lyzes the hydrolysis of the O-glycosidic -linkages between
galactosyl -1-3 N-acetylgalactosamine and a serine or threo-
nine residue in mucin-type glycoproteins (6, 9). On the other
hand, 1,2--L-fucosidases (E.C. 3.2.1.63) release terminal
-linked L-fucose from oligosaccharides of glycoconjugates,
including mucin glycoproteins. A member of this last family of
enzymes is present in Bifidobacterium bifidum JCM1254 (10,
14) and is encoded by the gene afcA. Both proteins are about
1,960 amino acids in length and contain a signal peptide and a
membrane anchor at the N and C termini, respectively. Thus,
they are predicted to be displayed on the bacterial surface,
thereby enabling the catalytic domains to gain access to extra-
cellular substrates.
In the present work, the presence of engBF and afcA was
tested in 22 strains of Bifidobacterium (Table 1) by using the
primers Fuc-F (5-TTCAACGAGGAGACGCTGTGGAC
CGG) and Fuc-R (5-GCCAGTAGTTCATCTGGAGGTTC
AC-3) and the primers Nac-F (5-CGTCAACTGGCAGGA
TGGCGCAATC-3) and Nac-R (5-CACCTTGAAGTGCTG
GATGAACTTAG-3), designed to amplify internal fragments
of 1,072 and 943 bp from the sequences of afcA (AY303700)
and engBF (AY836679), respectively. The annealing tempera-
ture for both amplifications was 45°C. The amplified DNA
fragments are located in the conserved sequence coding for the
catalytic domain of the enzymes. None of the genes were
detected in the Bifidobacterium animalis, Bifidobacterium
pseudocatenulatum, and Bifidobacterium breve strains tested.
This could be due to the lack of similar genes in the genomes
of these microorganisms or to a relatively low identity at the
DNA level between these three species and the species B.
longum and B. bifidum, from which the afcA and engBF genes
were initially sequenced. The gene engBF was present in all of
the strains of B. longum (14 isolates) and B. bifidum (2 iso-
lates), but only the B. bifidum strains contained afcA and
engBF (Table 1). All of the PCR products were sequenced, and
the predicted protein sequences were subjected to BLASTp
analysis (20) and compared with homologous sequences by
using as a query the sequences of B. bifidum D119 and L22
(Fig. 1). Both AfcA and EngBF internal fragments displayed
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the highest homology scores with several proteins from the
normal gut microbiota (Ruminococcus sp., Clostridium perfrin-
gens, Bacteroides sp., and Enterococcus faecalis; identities of 37
to 74% for EngBF and of 28 to 39% for AfcA), indicating the
ubiquity of these mucin-degrading enzymes among the bacte-
ria populating the intestine.
For growth experiments, a selection of Bifidobacterium
strains was used, taking into account the species and the pres-
ence or absence of glycosidase genes (Table 1). Cells were
grown in a defined medium (BM [see the supplemental mate-
rial]) to evaluate their ability to use mucin as a carbon source.
Fresh stabilized fecal samples (1) obtained from a healthy
adult donor who had not received antibiotics for the previous
6 months were used as the positive control. Bacterial cultures
grown overnight in 10 ml MRSC medium under standard con-
ditions (16), and stabilized fecal samples were washed with the
same volume of sterile 50 mM pH 7.0 phosphate buffer and
resuspended in 2 ml of sterile Ringer solution (0.25 strength;
Oxoid). This suspension was used to inoculate at 2% (vol/vol)
10 ml of BM with or without mucin (3 g/liter mucin from
porcine stomach type III [Sigma]), and samples were with-
drawn after 24 and 48 h of incubation. Differences in growth
were evident among the two strains of B. bifidum (D119 and
L22), B. breve NCIMB8807, and B. longum NCIMB8809, all of
them displaying the highest growth in the presence of mucin
after 48 h (Fig. 2). None of the B. animalis and B. pseudo-
catenulatum strains lacking both glycosidase genes or the three
B. longum human isolates harboring the engBF gene reached
differences in optical density at 600 nm (OD600) of greater than
0.5. In relation to this, it has previously been shown that B.
bifidum was the only species among 29 Bifidobacterium species
tested that was able to ferment porcine gastric mucin (3). Also,
an analysis of 18 different intestinal bacterial species showed
FIG. 1. Phylogenetic relationship analysis of the internal amino acid sequences of AfcA (Y665 to V950) (a) and EngBF (A614 to I903) (b).
Database accession numbers are in parentheses. Trees were constructed with the software MEGA4 (www.megasoftware.net), with the matrix of
pair distances between sequences by using the neighbor-joining cluster algorithm. The numbers at the branches are bootstrap values (confidence
limits). The bar scale refers to the number of amino acid substitutions per site.
TABLE 1. Microorganisms used in this study and amplification by




B. animalis IPLA4549b Culture collection  
B. bifidum D119b Human feces  
B. bifidum L22b Human feces  
B. longum C51 Human feces  
B. longum C61b Human intestinal mucosa  
B. longum C72 Human feces  
B. longum D12b Human feces  
B. longum H64 Human feces  
B. longum H92 Human feces  
B. longum L23 Human feces  
B. longum L43 Human feces  
B. longum L44 Human feces  
B. longum L45 Human feces  
B. longum M14 Human intestinal mucosa  
B. longum M25b Human feces  
B. longum M44 Human feces  
B. longum NCIMB8809b Culture collectionc  
B. pseudocatenulatum E114b Human feces  
B. pseudocatenulatum E514 Human feces  
B. pseudocatenulatum M115 Human intestinal mucosa  
B. pseudocatenulatum M63b Human feces  
B. breve NCIMB8807b Culture collectionc  
a Positive amplification () indicates that the sequence of the PCR product is
a homolog of that held in the NCBI database (accession numbers AY303700 and
AY836679).
b Strain selected for mucin-degrading assays.
c NCIMB, National Collection of Industrial, Marine, and Food Bacteria.
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that only Ruminococcus torques and B. bifidum were able to
partially ferment mucin (19). It is noteworthy that in a recent
study using human fecal samples as inocula to colonize porcine
gastric mucin, the sequences most commonly recovered from
mucin were from B. bifidum and Ruminococcus, suggesting the
competence of these bacteria to colonize this specific substrate
(12).
Mucin degradation was analyzed by gel permeation chroma-
tography. Samples obtained after 48 h of incubation from BM
containing mucin were centrifuged, and supernatants were col-
lected to check polymer degradation. Samples were isocrati-
cally separated at 0.450 ml/min by using 0.1 M NaNO3 in two
columns of TSK-Gel G3000PWXL and G5000PWXL (Supelco)
placed in series as previously described (17). Several concen-
trations of dextran standards (Fluka) with different molecular
masses (5  103, 5  104, 8  104, 2.7  105, 6.7  105, 1.4 
106, and 4.9 106 Da) were run for molecular mass calibration
and quantification. In BM containing mucin, a high-molecular-
mass peak (5  105 Da) and several small peaks (1  103
Da) were apparent in the chromatograms (Fig. 3a), whereas
after 48 h of incubation with stabilized fecal samples, the high-
molecular-mass peak completely disappeared and changes in
the other peaks were also detected. Thus, we considered the
decrease in the highest-molecular-mass peak to be an indicator
of mucin degradation. Accordingly, most of the strains tested
were unable to degrade mucin (Fig. 3b). However, the two B.
bifidum strains were able to degrade more than 80% of the
high-molecular-mass mucin glycoproteins after 48 h of incuba-
tion. Furthermore, B. longum NCIMB8809 and B. breve
NCIMB8807 displayed an intermediate level of degradation
compared with the other Bifidobacterium strains, in spite of the
fact that none of the genes were present in the B. breve strain.
Thus, probably other genes, not considered in the present
work, or genes with a similar function but with low homology
to those used in the present study could also be involved in the
degradation of mucin by B. breve NCIMB8807.
Considering the aforementioned results, the two B. bifidum
strains analyzed in this study seem to possess a higher capacity
to degrade intestinal mucin. To establish a correlation between
this capacity and the likely involvement of afcA and engBF in
mucin degradation, the influence of mucin and/or glucose on
the expression levels of the afcA and engBF genes in strain B.
bifidum L22 was assessed. The bacterium was grown in BM in
the presence of 20 g/liter glucose and/or 3 g/liter mucin to an
OD600 of 1 	 0.2 as described above. Specific primers were
designed by using the sequences obtained from the genes afcA
(forward, 5-ACACCGCCGTCAAGAAAGC-3; reverse, 5-
CGATCTTCACGCGGTCGTA-3) and engBF (forward, 5-G
CTCCCAGGCGCAGAAC-3; reverse, 5-TGTTGAGGGCG
ACCTTCTTG-3) of B. bifidum L22. Lysis, total RNA
extraction, and quantitative PCR analysis were carried out as
previously described (7), with an ABI Prism 7500 machine
(Applied Biosystems). Both genes were strongly induced in the
presence of mucin and mucin plus glucose but not in the
presence of glucose alone (Fig. 4). This suggests that these two
mucin-degrading glycosidases are transcriptionally regulated in
B. bifidum by the presence of mucin.
In summary, we have shown for the first time that several
intestinal bifidobacteria, especially two B. bifidum isolates,
are able to degrade intestinal mucin in vitro to different
FIG. 2. OD600s of cultures of Bifidobacterium strains reaching values higher than 0.5 and a fecal sample growing in BM in absence (a) or
presence (b) of mucin. The difference in OD600 between the presence and absence of mucin for 10 Bifidobacterium strains is depicted for cultures
at 48 h (c). Results are the average of three independent cultures, and the coefficients of variation ranged between 1 and 35%.
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extents. This degradation capacity seems to have a correla-
tion with the presence of two genes coding for extracellular
glycosidases, afcA and engBF. Intraspecies differences were
also detected in B. longum, since only strain NCIMB8809
was able to degrade mucin significantly; however, all B.
longum strains have engBF, suggesting that the presence of
this gene is not the only factor affecting the degradation
capacity in question. In addition, B. breve NCIMB8807 is
able to degrade mucin to some extent but it seems not to
harbor these genes. The reactions catalyzed by the products
of the afcA and engBF genes could represent the first step in
the degradation of mucin sugars by B. longum and B. bifi-
dum. The galactosyl -1-3 N-acetylgalactosamine released
extracellularly from mucin glycoconjugates by EngBF could
be transported into the cell by a putative ABC transporter,
entering the galacto-N-biose metabolic pathway recently de-
scribed in B. longum (11, 15) and finally being metabolized
through the glycolytic pathway or by amino sugar metabo-
lism, thus serving as a carbon and energy source for bi-
fidobacteria. Results shown here open an interesting debate
on probiotic safety criteria regarding intestinal mucus deg-
radation, which was until now considered a hazardous se-
lection property.
Nucleotide sequence accession numbers. The partial nucle-
otide sequences of afcA obtained in this study are available in
the GenBank database under accession numbers EU260397
and EU260398 for positive strains appearing in the same order
given in Table 1 from top to bottom. The partial nucleotide
sequences of engBF obtained in this study are available in the
GenBank database under accession numbers EU260399 to
EU260414 for positive strains appearing in the same order
given in Table 1 from top to bottom.
FIG. 3. Degradation of mucin by 10 Bifidobacterium strains after 48 h of growth in BM in the presence of mucin. (a) Chromatograms of BM
containing 0.3% mucin, the supernatant of the positive mucin-degradation control (feces) after 48 h of incubation, and B. bifidum L22 culture
supernatant after 48 h of incubation. (b) Amount of the highest (5 105 Da) peak. The dotted line indicates the maximum value of mucin initially
present in the culture medium. For sample peak quantification (
g/ml), the linear regression equations (R2  0.994 	 0.004) for each standard
were calculated from at least three replicated measurements of each concentration. A linear regression equation (R2  0.995) was also calculated
to determine the molecular masses (in daltons) of the sample peaks.
FIG. 4. Levels of B. bifidum L22 afcA and engBF gene expression
in four culture media, i.e., BM (black), BM plus 2% glucose (white),
BM plus 0.3% mucin (dark gray), and BM plus 2% glucose plus
0.3% mucin (light gray). The expression levels shown are relative to
those obtained in the control culture (BM). Experiments were car-
ried out in duplicate and analyzed in duplicate in two independent
PCR runs.
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